0.549

1.81% -0.0101

Accelerate Diagnostics Inc (AXDX)

Overview News Price History Financials Why AXDX Down? Discussions Forecast Stock Split

Accelerate Diagnostics Inc stock is traded at $0.549, with a volume of 5,223. It is down -1.81% in the last 24 hours and down -49.63% over the past month. Accelerate Diagnostics Inc is an in vitro diagnostics company dedicated to providing solutions that improve patient outcomes and lower healthcare costs through the rapid diagnosis of serious infections. Its Clinical Microbiology products include Accelerate Pheno system, Accelerate PhenoTest BC Kit, and Accelerate Arc module & BC kit. The company earns the majority of its revenue from the domestic market. The group operates as one operating segment, deriving instrument, consumable, and service revenues from customers engaged in healthcare diagnostics within the United States. Product revenue is derived from the sale or rental of instruments and sales of related consumable products. Service revenue is derived from the sale of extended service agreements.

Previous Close:

$0.5591

Open:

$0.5602

24h Volume:

5,223

Relative Volume:

0.12

Market Cap:

$13.67M

Revenue:

$12.00M

Net Income/Loss:

$-63.23M

P/E Ratio:

-0.0915

EPS:

-6

Net Cash Flow:

$-43.02M

1W Performance:

-5.34%

1M Performance:

-49.63%

6M Performance:

-68.63%

1Y Performance:

-25.46%

1-Day Range:

$0.5144

$0.5748

1-Week Range:

$0.50

$0.6358

52-Week Range:

$0.49

$2.09

Accelerate Diagnostics Inc Stock (AXDX) Company Profile

Name

Accelerate Diagnostics Inc

Sector

Healthcare (1151)

Industry

Medical Devices (153)

Phone

303-863-8088

Address

3950 S. COUNTRY CLUB ROAD #470, TUCSON, AZ

Employee

107

Twitter

@AXDXNews

Next Earnings Date

2024-11-07

Latest SEC Filings

AXDX's Discussions on Twitter

Compare AXDX with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
AXDX Accelerate Diagnostics Inc	0.549	13.67M	12.00M	-63.23M	-43.02M	-6.00
ABT Abbott Laboratories	130.98	221.92B	41.95B	13.40B	6.35B	7.65
BSX Boston Scientific Corp	95.12	139.43B	16.75B	1.85B	2.37B	1.25
SYK Stryker Corp	346.50	134.90B	22.60B	2.99B	3.49B	7.76
MDT Medtronic Plc	82.60	108.02B	33.20B	4.26B	5.47B	3.29
EW Edwards Lifesciences Corp	71.53	40.93B	5.72B	4.17B	259.90M	6.97

Accelerate Diagnostics Inc Stock (AXDX) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Mar-09-22	Downgrade	Craig Hallum	Buy → Hold
Oct-08-20	Initiated	BTIG Research	Neutral
Aug-07-20	Upgrade	Craig Hallum	Hold → Buy
Sep-27-19	Downgrade	JP Morgan	Neutral → Underweight
Nov-07-18	Downgrade	JP Morgan	Overweight → Neutral
May-24-18	Initiated	Craig Hallum	Hold
Dec-13-17	Downgrade	BTIG Research	Buy → Neutral
Jul-12-17	Resumed	BTIG Research	Buy
Mar-24-16	Initiated	JP Morgan	Overweight
Dec-16-15	Initiated	Piper Jaffray	Overweight

View All

Accelerate Diagnostics Inc Stock (AXDX) Latest News

Apr 18, 2025

Accelerate Diagnostics (NASDAQ:AXDX) Coverage Initiated by Analysts at StockNews.com - Defense World

Apr 18, 2025

Apr 15, 2025

Accelerate Diagnostics adds new independent directors By Investing.com - Investing.com Canada

Apr 15, 2025

Accelerate Diagnostics board forms committee to exlore strategic alternatives - TipRanks

Apr 15, 2025

Apr 09, 2025

Renovaro and BioSymetrics Close Merger to Accelerate AI-Driven Biomarker Discovery and Precision Medicine - Yahoo Finance

Apr 09, 2025

Apr 08, 2025

Accelerate Diagnostics CEO Jack Phillips sells $16,472 in stock - Investing.com Australia

Apr 08, 2025

Apr 07, 2025

Accelerate Diagnostics CTO sells shares worth $989 - Investing.com

Apr 07, 2025

Accelerate Diagnostics CTO sells shares worth $989 By Investing.com - Investing.com South Africa

Apr 07, 2025

Accelerate Diagnostics CEO Sells Shares to Cover Tax Obligations - TradingView

Apr 07, 2025

AXDX stock touches 52-week low at $0.63 amid market challenges - Investing.com India

Apr 07, 2025

Accelerate Diagnostics CEO Jack Phillips sells $16,472 in stock By Investing.com - Investing.com Canada

Apr 07, 2025

Apr 04, 2025

Microbial Identification Methods Market Forecasted to Grow at 6.64% CAGR, Reaching $8.16 Billion by 2030The Insight Partners - Yahoo Finance

Apr 04, 2025

Automotive Diagnostics Scanner Market to Accelerate Growth with Actron, Denso, Launch Tech - newstrail.com

Apr 04, 2025

Apr 02, 2025

Accelerate Diagnostics CFO sells shares worth $4,839 By Investing.com - Investing.com South Africa

Apr 02, 2025

Accelerate Diagnostics CFO sells shares worth $4,839 - Investing.com

Apr 02, 2025

Accelerate Diagnostics (NASDAQ:AXDX) Shares Pass Below 200 Day Moving Average – What’s Next? - Defense World

Apr 02, 2025

Mar 28, 2025

AXDX stock touches 52-week low at $0.73 amid market challenges By Investing.com - Investing.com South Africa

Mar 28, 2025

AXDX stock touches 52-week low at $0.73 amid market challenges - Investing.com Australia

Mar 28, 2025

Mar 26, 2025

Accelerate Diagnostics Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Mar 26, 2025

Mar 25, 2025

Accelerate Diagnostics (NASDAQ:AXDX) Now Covered by Analysts at StockNews.com - Defense World

Mar 25, 2025

Accelerate Diagnostics Reports 2024 Financial Results - TipRanks

Mar 25, 2025

Mar 24, 2025

Antimicrobial Susceptibility Testing Market Expecting Huge Demand in Upcoming Years Accelerate Diagnostics - openPR.com

Mar 24, 2025

Accelerate Diagnostics Inc expected to post a loss of 49 cents a shareEarnings Preview - TradingView

Mar 24, 2025

Mar 21, 2025

Accelerate Diagnostics seeks FDA clearance for WAVE system By Investing.com - Investing.com Australia

Mar 21, 2025

Accelerate Diagnostics seeks FDA clearance for WAVE system - Investing.com India

Mar 21, 2025

InventHelp Inventor Develops Modified Single-Serve Coffeemaker (KXK-162) - The Malaysian Reserve

Mar 21, 2025

Accelerate Diagnostics Submits WAVE System and Gram-Negative Positive Blood Culture Menu to the FDA for 510(k) Clearance - PR Newswire

Mar 21, 2025

Accelerate Diagnostics Reports Fourth Quarter and Full-Year 2024 Financial Results - PR Newswire

Mar 21, 2025